Pharmacology, Toxicology and Pharmaceutical Science
Allodynia
14%
Amino Acid
13%
Analgesic Agent
32%
Antinociception
33%
Antiplasmin
7%
Arginine
7%
Biological Activity
20%
Biphalin
10%
Blood Clotting Factor 13
6%
Blood-Brain Barrier
6%
Bone Pain
8%
Bradykinin Receptor
9%
Calcitonin Gene Related Peptide
9%
Cannabinoid
6%
Cannabinoid 2 Receptor
5%
Cannabinoid 2 Receptor Agonist
5%
Cannabinoid Receptor
6%
Capsaicin
8%
Carbon Monoxide
35%
Cholecystokinin
7%
Cholecystokinin Receptor
5%
Chronic Pain
38%
Collapsin Response Mediator Protein 2
18%
Crotalus atrox
6%
Delta Opiate Receptor
20%
Delta Opiate Receptor Agonist
9%
Deltorphin
16%
Disease
13%
Drug Development
6%
Dynorphin
18%
Dynorphin A
23%
Endorphin
14%
Enkephalin
44%
Enkephalin Derivative
12%
enkephalin[2,5 Dextro Penicillamine]
12%
Epileptic Absence
5%
Erethism
17%
Fibrinogen
13%
Fibrinolytic Agent
8%
Formaldehyde
5%
Glycopeptide
6%
Guinea Pig
13%
Headache
5%
Heme
6%
Hetastarch
10%
Hyperalgesia
14%
Hypercoagulability
7%
IC50
11%
Ileum
12%
Inflammation
13%
Inflammatory Pain
6%
Injury
15%
Intrathecal
23%
Ischemia
6%
Kappa Opiate Receptor
7%
Lacosamide
5%
Leporidae
10%
Malignant Neoplasm
9%
Mechanical Allodynia
5%
Migraine
8%
Morphine
63%
Mouse
66%
Mu Opiate Receptor Agonist
7%
Naloxone
14%
Naltrindole
11%
Narcotic Agent
7%
Nerve Injury
13%
Neurokinin 1 Receptor Antagonist
13%
Neuronal Nitric Oxide Synthase
9%
Neuropathic Pain
51%
Nitric Oxide Synthase Inhibitor
6%
Opiate
86%
Opiate Agonist
43%
Opiate Peptide
18%
Opiate Receptor
89%
Opioid Antagonist
11%
Opioid-Induced Hyperalgesia
6%
Pain
14%
Peroxynitrite
6%
Potassium Channel
5%
Rat Model
5%
Receptor
66%
Receptor Subtype
12%
Side Effect
18%
Snake Venom
6%
Sodium Channel
9%
Structure Activity Relationship
14%
Tactile Allodynia
5%
Thermal Hyperalgesia
8%
Thrombin
10%
Thrombin Activatable Fibrinolysis Inhibitor
5%
Thromboplastin
13%
Thrombus
6%
Tissue Plasminogen Activator
8%
Tubulin
6%
Voltage Gated Calcium Channel
5%
Voltage Gated Sodium Channel
7%
Xanthine Oxidase
7%
μ-Opioid Receptor
10%
Neuroscience
Agonist
65%
Allodynia
40%
Alzheimer's Disease
5%
Amino Acid
5%
Analgesic
5%
Anterior Cingulate Cortex
9%
Antisense Oligodeoxynucleotide
10%
Arginine
7%
Aspartic Acid
7%
Behavior (Neuroscience)
28%
Binding Affinity
7%
Binding Site
10%
Blood Brain Barrier
10%
Bombesin
7%
Brainstem
6%
Calcitonin
15%
Calcium Channel
14%
Cannabinoid
8%
Capsaicin
11%
Carbon Monoxide
19%
Central Nervous System
12%
Cholecystokinin
9%
Cognitive Disorders
5%
Collapsin Response Mediator Protein
6%
Collapsin Response Mediator Protein 2
39%
Conditioned Place Preference
7%
Cyclin Dependent Kinase 5
5%
Delta Opiate Receptor
22%
Deltorphin
23%
Dendrite
6%
Dorsal Root Ganglion
17%
Dynorphin
18%
Dynorphin A
12%
Eicosanoid Receptor
42%
Endorphin
15%
Enkephalin
51%
Enkephalin Derivative
5%
enkephalin[2,5 Dextro Penicillamine]
10%
Epileptic Absence
5%
Headache
21%
Hyperalgesia
34%
Ileum
7%
In Vitro
21%
In Vivo
33%
Information Processing
5%
Intrathecal
31%
Ion Channel
5%
Ion Transport
5%
Lacosamide
10%
Medication Overuse
9%
Medulla
5%
Microtubule
20%
Migraine
18%
Morphine
76%
Naloxone
15%
Naltrindole
17%
Neurofibromatosis Type 1
7%
Neuropathic Pain
68%
Neurotransmission
7%
Neurotransmitter Release
13%
Neurotrauma
7%
Nitric Oxide
8%
Nociception
11%
Nociceptor
13%
Norbinaltorphimine
5%
Nucleus Accumbens
9%
Opiate
100%
Opioid Antagonist
13%
Opioid Peptide
8%
Peripheral Nerve
6%
Potassium Channel
5%
Receptor Agonists
15%
Receptor Antagonist
7%
Receptor Potential
6%
Receptor Subtype
12%
Resiniferatoxin
5%
Rostral Ventromedial Medulla
14%
Sensory Neuron
21%
Small Interfering RNA
5%
Sodium Channel
10%
Spinal Nerve
26%
Spreading Cortical Depression
7%
Sumoylation
5%
Tetrodotoxin
6%
Thromboplastin
8%
Traumatic Brain Injury
7%
Trigeminal Ganglion
6%
TRPV1
6%
Vanilloid Receptor 1
8%
Voltage Gated Calcium Channel
7%
Voltage Gated Sodium Channel
8%
δ -Opioid Receptor
89%
Κ-opioid receptor
11%
μ-Opioid Receptor
10%
Keyphrases
Agonist Activity
8%
AM1241
5%
Analgesia
8%
Analgesic
6%
Anesthesia
5%
Antagonism
13%
Antagonist Activity
8%
Antinociception
34%
Antinociceptive
43%
Antinociceptive Tolerance
7%
Antisense Oligonucleotides
8%
Aortic Occlusion
7%
Binding Affinity
12%
Binding Site
10%
Biological Activity
15%
Biological Evaluation
6%
Biphalin
8%
Bradykinin Receptor
5%
Calcitonin Gene-related Peptide
7%
Cannabinoid Receptor 1 (CB1R)
6%
Capsaicin
7%
Carbon Dioxide
14%
Cardiac Arrest
5%
CaV2.2
8%
Central Nervous System
6%
Cholecystokinin
7%
Chronic Neuropathic Pain
7%
Chronic Pain
18%
Clot Strength
7%
Coagulation Kinetics
7%
Corm
11%
CORM-2
7%
CRMP2
17%
Delta Receptor
15%
Deltorphin
13%
Descending Facilitation
5%
DPDPE
11%
Dynorphin
15%
Dynorphin A
12%
Enkephalin
52%
Enkephalin Analogues
8%
Epinephrine
5%
Evoked Pain
5%
Fibrinogen
5%
Fibrinolysis
12%
Gastrointestinal Transit
5%
Halothane
5%
High Affinity
6%
Highly Selective
6%
Human Plasma
11%
Hyperalgesia
8%
Hypercoagulability
7%
Intrathecal
10%
Intrathecal Administration
5%
Kappa Opioid Receptor
9%
Microtubules
10%
Morphine
49%
Morphine Antinociception
9%
Mouse Brain
6%
Mouse Vas Deferens
6%
Naloxone
8%
Naltrindole
16%
Nav1.7
6%
Nerve Injury
7%
Neurokinin-1 Receptor Antagonist
9%
Neuropathic Pain
35%
Nonapeptides
6%
Nor-binaltorphimine (nor-BNI)
5%
Opiates
5%
Opioid Activity
6%
Opioid Agonist
18%
Opioid Antagonist
27%
Opioid Peptides
11%
Opioid Receptors
70%
Opioids
40%
Pain Relief
6%
Pain Treatment
6%
Pharmacophore
11%
Phosphorylation
6%
Rat Brain
10%
Receptor Subtypes
11%
Receptor-mediated
5%
Reperfusion
6%
Resuscitation
8%
Rostral Ventrolateral Medulla
7%
Side Chain
6%
Spinal Cord
8%
Spinal Nerve Ligation
11%
Structure-activity Relationship
8%
Supraspinal
10%
Synthetic Evaluation
7%
Tetrapeptide
6%
Thromboelastography
8%
Tissue Factor
7%
Transient Receptor Potential Vanilloid 1 (TRPV1)
6%
U50,488
5%
Venom
7%
Xanthine Oxidase
6%
δ Opioid Receptor
12%
μ-opioid Receptor
8%